These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22302066)

  • 21. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children.
    Connell TG; Ritz N; Paxton GA; Buttery JP; Curtis N; Ranganathan SC
    PLoS One; 2008 Jul; 3(7):e2624. PubMed ID: 18612425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients.
    Jiang B; Ding H; Zhou L; Chen X; Chen S; Bao C
    Int J Rheum Dis; 2016 Jan; 19(1):38-42. PubMed ID: 26820838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study.
    Gupta RK; Lipman M; Jackson C; Sitch AJ; Southern J; Drobniewski F; Deeks JJ; Tsou CY; Griffiths C; Davidson J; Campbell C; Stirrup O; Noursadeghi M; Kunst H; Haldar P; Lalvani A; Abubakar I
    Am J Respir Crit Care Med; 2020 Apr; 201(8):984-991. PubMed ID: 31825645
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis.
    Lee YM; Park KH; Kim SM; Park SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Infection; 2013 Dec; 41(6):1089-95. PubMed ID: 23943073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of tuberculin skin test and three interferon-gamma release assays for the differential diagnosis of pulmonary tuberculosis.
    Kobashi Y; Abe M; Mouri K; Obase Y; Miyashita N; Oka M
    Intern Med; 2012; 51(10):1199-205. PubMed ID: 22687790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.
    Mínguez S; Latorre I; Mateo L; Lacoma A; Diaz J; Olivé A; Domínguez J
    Clin Rheumatol; 2012 May; 31(5):785-94. PubMed ID: 22271230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region.
    Chung CY; Li KKW
    Int Ophthalmol; 2018 Dec; 38(6):2273-2282. PubMed ID: 28948453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.
    Kampmann B; Whittaker E; Williams A; Walters S; Gordon A; Martinez-Alier N; Williams B; Crook AM; Hutton AM; Anderson ST
    Eur Respir J; 2009 Jun; 33(6):1374-82. PubMed ID: 19196815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection].
    Borkowska D; Zwolska Z; Michałowska-Mitczuk D; Korzeniewska-Koseła M; Zabost A; Napiórkowska A; Kozińska M; Brzezińska S; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2011; 79(4):264-71. PubMed ID: 21678276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study.
    Bamford AR; Crook AM; Clark JE; Nademi Z; Dixon G; Paton JY; Riddell A; Drobniewski F; Riordan A; Anderson ST; Williams A; Walters S; Kampmann B
    Arch Dis Child; 2010 Mar; 95(3):180-6. PubMed ID: 19815937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?
    Ling DI; Pai M; Davids V; Brunet L; Lenders L; Meldau R; Calligaro G; Allwood B; van Zyl-Smit R; Peter J; Bateman E; Dawson R; Dheda K
    Eur Respir J; 2011 Sep; 38(3):649-56. PubMed ID: 21349910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of the Combination of Tuberculin Skin Test and Interferon-Gamma Release Assay in Diagnosing Children with Tuberculosis.
    Shimizu H; Mori M
    Tohoku J Exp Med; 2017 Nov; 243(3):205-210. PubMed ID: 29187669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.